Explore a curated collection of IBAL publications on Harvard Dataverse, featuring preclinical and clinical studies of Ion Biotechnology Aqueous Ligands (IBAL) — an advanced ion-based coordination system with wide-ranging applications in health and medicine.

The research highlights IBAL’s powerful anticancer, antifungal, antiviral, and antibacterial activities, showcasing its potential across various therapeutic areas. These studies offer insight into how IBAL works to fight resistant pathogens, reduce oxidative stress, and support tissue healing.

This is an ideal resource for scientists, clinicians, and innovators seeking credible, peer-reviewed data on one of the most promising advances in biomedical ion technology.